smallmolecul
fragment
bind
biomacromolecul
start
point
develop
drug
often
difficult
detect
due
low
affin
present
strategi
identifi
proteinbind
fragment
potenti
induc
targetguid
format
coval
bound
irrevers
enzym
inhibitor
proteinbind
nucleophil
react
revers
biselectrophil
warhead
therebi
posit
second
electrophil
close
proxim
activ
site
viral
proteas
result
coval
deactiv
enzym
concept
implement
coxsacki
viru
proteas
pharmacolog
target
enterovir
infect
use
aldehydeepoxid
biselectrophil
activ
fragment
combin
valid
measur
protein
inactiv
rate
detect
coval
protein
modif
mass
spectrometri
structur
one
enzymeinhibitor
complex
determin
xray
crystallographi
present
warhead
activ
assay
provid
potent
nonpeptid
broadspectrum
inhibitor
enterovir
proteas
present
bioactiv
protein
ligand
discov
mostli
screen
chemic
librari
employ
suitabl
bioassay
test
system
contrast
classic
screen
templat
assembl
protein
ligand
bioassay
could
tantal
altern
potenti
identifi
noncanon
protein
ligand
improv
potenc
ligand
effici
select
employ
reduc
human
ecolog
financi
resourc
proteintempl
reaction
driven
kinet
enhanc
ligandform
reaction
thermodynam
stabil
proteinbind
ligat
product
combin
case
howev
enhanc
bind
fragment
ligat
product
accompani
shift
ligat
equilibrium
templat
enhanc
format
bound
ligat
product
enhanc
bind
fragment
ligat
product
correspond
overaddit
fragment
bind
detect
sensit
biochem
biophys
experi
revers
irrevers
reaction
employ
format
protein
ligand
coval
templat
assembl
contribut
investig
combin
revers
templat
reaction
irrevers
templat
reaction
enabl
proteinguid
assembl
protein
ligand
subsequ
reaction
irrevers
enzym
inhibitor
describ
reaction
sequenc
enabl
test
combin
nucleophil
fragment
electrophil
warhead
biochem
assay
inhibitori
fragment
combin
detect
warhead
activ
assay
use
blueprint
construct
potent
irrevers
enzym
inhibitor
describ
warhead
activ
assay
ration
structur
kinet
analysi
form
fragment
ligat
product
support
molecular
model
put
intermediari
fragmentprotein
complex
sitespecif
bind
sever
inhibitor
verifi
protein
mass
spectrometri
structur
one
enzymeinhibitor
complex
determin
protein
crystallographi
potent
inhibitor
possess
broadband
submicromolar
activ
toward
panel
seven
enteroand
rhinovir
proteas
indic
feasibl
fragment
ligat
approach
describ
concept
fragmentwarhead
activ
assay
envisag
fragmentwarhead
activ
assay
base
idea
templat
ligat
reaction
proteinbind
fragment
electrophil
warhead
lead
acceler
irrevers
inhibit
protein
reactiv
protein
nucleophil
present
fig
concept
nucleophil
smallmolecul
fragment
bind
bind
site
protein
fig
step
proteinbind
fragment
undergo
revers
ligat
reaction
biselectrophil
proteinreact
group
warhead
step
ligat
reaction
therebi
posit
second
reactiv
electrophil
function
warhead
activ
site
protein
induc
irrevers
coval
reaction
activesit
nucleophil
warhead
step
result
irrevers
deactiv
protein
describ
reaction
sequenc
enabl
test
combin
nucleophil
fragment
electrophil
warhead
biochem
assay
inhibitori
fragment
combin
detect
warhead
activ
assay
blueprint
construct
potent
irrevers
enzym
inhibitor
select
protein
target
protein
target
proteas
coxsacki
viru
proteas
select
coxsacki
virus
member
larg
genu
enterovirus
repres
uncoat
positivestrand
rna
virus
picornaviru
famili
caus
numer
human
diseas
includ
mening
myocard
diarrhea
genu
enteroviru
compris
numer
human
pathogen
includ
rhinovirus
poliovirus
echovirus
humaninfect
virus
like
ref
coxsacki
viru
proteas
like
enterovir
proteas
cystein
proteas
characterist
specif
glutamin
posit
substrat
fig
thu
target
fragment
bind
pocket
biomimet
glutamin
side
chain
activesit
nucleophil
thiolat
cystein
develop
warhead
activ
assay
sever
biselectrophil
consid
warhead
warhead
activ
assay
enantiomer
pure
ethyl
select
prepar
commerci
avail
ethyl
enoat
warhead
contain
aldehyd
epoxid
function
electrophil
reaction
site
ligat
proteinbind
nucleophil
fragment
irrevers
alkyl
reaction
activesit
cystein
proteas
structur
deriv
natur
cystein
proteas
inhibitor
recogn
privileg
reactiv
warhead
target
cystein
proteas
step
step
step
b
figur
concept
fragmentwarhead
activ
assay
proteintempl
coval
assembl
irrevers
inhibitor
cystein
proteas
revers
bind
nucleophil
fragment
nu
nucleophil
step
posit
biselectrophil
warhead
templat
dynam
reaction
activ
site
protein
step
lead
irrevers
inhibit
protein
step
case
nu
amin
nucleophil
nu
nhr
imin
intermedi
instead
depict
hemiamin
may
form
b
activ
site
enteroviru
proteas
bound
peptid
substrat
contain
glutamin
residu
gln
q
posit
occupi
pocket
enzym
alon
investig
inhibitor
proteas
coxsacki
viru
fig
employ
enzymat
proteas
assay
substrat
contain
fluorescencereson
energi
transfer
fret
pair
fragment
identifi
weak
irrevers
inhibitor
proteas
rel
inactiv
rate
k
inact
k
valu
inactiv
rate
correspond
appar
halfmaxim
inhibitori
concentr
ic
valu
mm
min
fig
tabl
coval
mode
action
confirm
electrospray
ioniz
highresolut
ion
mobil
spectrometrymass
spectrometri
esim
measur
incub
proteas
warhead
shift
main
deconvolut
mass
peak
protein
da
observ
protein
mass
differ
da
correspond
well
molecular
weight
biselectrophil
hydrolysi
ethyl
ester
next
fragment
ligat
assay
conduct
identifi
nucleophil
fragment
induc
deactiv
protein
ligat
reaction
fragment
purpos
concentr
fragment
determin
decreas
activ
proteas
time
period
min
level
inhibit
use
ascertain
maxim
sensit
assay
small
librari
primari
amin
fragment
compos
appli
substructur
analysi
world
drug
index
screen
fragment
ligat
assay
fragment
fig
supplementari
tabl
display
strongest
overaddit
effect
inhibit
proteas
activ
fragment
alon
reduc
enzym
activ
proteas
inhibit
complet
combin
concentr
fig
incub
proteas
mixtur
equiv
equiv
led
concentrationdepend
deactiv
enzym
appar
ic
valu
ca
mm
k
inact
k
supplementari
fig
deconvolut
esim
proteas
ligat
mixtur
fragment
show
modif
protein
mass
addit
fragment
da
major
mass
peak
intens
see
fig
comparison
mass
peak
remain
unmodifi
protein
display
intens
protein
coupl
biselectrophil
alon
ca
support
assumpt
protein
modif
strongli
amplifi
presenc
fragment
incub
mutat
proteas
ref
display
modif
ms
indic
select
alkyl
activ
site
compound
number
k
inact
k
ligat
reaction
fragment
analys
hplcm
without
protein
target
present
supplementari
fig
sever
differ
addit
product
form
accord
mass
analysi
retent
time
two
product
addit
mass
fragment
observ
deconvolut
ms
protein
sampl
react
fragment
format
sever
differ
addit
product
agreement
report
reactiv
found
react
electrophil
exocycl
amino
group
carbonyl
oxygen
posit
product
ratio
vari
strongli
depend
solvent
presenceabs
protein
target
isol
form
ligat
product
prepar
column
chromatographi
furnish
mixtur
compound
indic
form
revers
equilibrium
reaction
evalu
potenti
variou
ligat
product
inhibitor
possibl
fragment
combin
gener
silico
dock
activ
site
dock
pose
select
accord
abil
bind
react
similar
manner
observ
pdb
entri
repres
crystal
structur
proteas
particular
two
criteria
appli
hydrogenbond
pattern
lactam
moieti
cocrystal
ligand
pocket
fulfil
dock
pose
plausibl
posit
bind
site
ii
distanc
cystein
sulfur
potenti
coval
bind
electrophil
ligat
product
reason
rang
subsequ
coval
bind
supplementari
tabl
dock
fragment
suggest
bind
pocket
proteas
occupi
posit
primari
amid
nativ
glutamin
residu
fig
sampl
variou
reaction
path
electrophil
nucleophil
posit
fragment
support
best
fit
nucleophil
attack
ring
posit
fig
accord
dock
experi
put
reaction
product
secondari
alcohol
posit
activ
site
protein
attack
result
open
epoxid
ring
format
coval
protein
modif
fig
fragmentbas
inhibitor
design
base
observ
fragment
potent
activ
biselectrophil
induc
assembl
irrevers
proteas
inhibitor
set
fragment
combin
design
vari
chemic
natur
attach
proteinreact
electrophil
fig
tabl
supplementari
tabl
transepoxid
moder
activ
irrevers
inhibitor
proteas
k
inact
k
transepoxid
revers
inhibitor
enzym
cisepoxid
inact
expect
amid
design
accord
recent
report
increas
reactiv
proteas
observ
altern
electrophil
link
primari
fragment
acryl
ester
deriv
weak
irrevers
inhibitor
k
inact
k
ethyl
fumaroyl
electrophil
contain
also
transolefin
rais
rel
inactiv
rate
initi
electrophil
electrophil
nfumaroyl
ester
inact
posit
shown
compound
convert
stereochemistri
doubl
bond
furnish
nmaleoyl
ester
display
impress
inactiv
rate
assur
inhibit
effect
aminopyrazolon
fragment
unsubstitut
maleoyl
amid
ester
prepar
found
moder
activ
transform
ethyl
ester
ethyl
amid
reduc
inactiv
rate
maleoyldiamid
fulli
inact
enhanc
inactiv
accomplish
transvinyl
sulfon
display
maxim
inactiv
rate
broadspectrum
inhibitor
viral
proteas
three
potent
inhibitor
cbv
proteas
deriv
aminopyrazolon
fragment
maleoyl
ester
maleoyldiamid
vinyl
sulfon
test
toward
panel
six
addit
rhinovir
enterovir
proteas
equin
rhiniti
b
viru
human
rhinoviru
human
enteroviru
aichi
viru
porcin
sapeloviru
human
enteroviru
protein
inhibitor
stoichiometri
fig
inhibitor
condit
strongli
reduc
activ
six
proteas
investig
gener
potent
compound
show
highest
inhibit
fulli
inhibit
enzym
even
one
inhibitor
equival
inhibitori
activ
decreas
ic
valu
activ
compound
determin
incub
fix
enzym
concentr
h
differ
concentr
inhibitor
tabl
potent
inhibitor
compound
show
submicromolar
inhibit
test
viral
proteas
strongest
inhibit
follow
final
proteas
test
activ
final
select
repres
inhibitor
valid
use
four
proteas
possess
nucleophil
aminoacid
residu
activ
site
name
serin
proteas
trypsin
chymotrypsin
factor
xa
cystein
proteas
four
enzym
cover
broad
rang
name
argininelysin
trypsin
factor
xa
hydrophob
residu
chymotrypsin
aspart
compound
inact
toward
four
proteas
ic
mm
compound
inact
toward
three
serin
proteas
ic
mm
reveal
low
inhibit
cystein
proteas
ic
mm
supplementari
tabl
structur
proteas
inhibitor
compound
incub
proteas
enzym
repurifi
sizeexclus
chromatographi
subject
crystal
trial
protein
complex
gave
welldiffract
crystal
show
presenc
addit
electron
densiti
activ
site
correspond
molecular
structur
inhibitor
highresolut
structur
pdb
proteaseinhibitor
complex
reveal
sever
addit
aspect
inhibit
proteas
compound
describ
dock
studi
exclus
electrophil
attack
coval
link
nucleophil
form
stabl
tetrahedr
michael
addit
product
fig
result
insert
solventexpos
bstrand
loop
form
occupi
subpocket
protein
refer
inhibitor
fig
attack
see
asterisk
carbonyl
oxygen
ethyl
amid
orient
toward
oxyanion
hole
form
hydrogenbond
network
backbon
amid
nethyl
group
point
pocket
pyrazolon
ring
sandwich
pocket
p
p
interact
peptid
bond
one
side
side
nh
interact
water
molecul
mediat
hydrogen
bond
addit
plausibl
hydrogen
bond
identifi
pyrazolon
ring
well
water
molecul
support
interact
cycloheptan
show
weak
electron
densiti
indic
flexibl
orient
part
molecul
protein
surfac
van
der
waal
interact
observ
ring
atom
sidechain
c
b
atom
summari
crystal
structur
show
bind
compound
distinct
establish
inhibitor
sever
aspect
contribut
understand
observ
inhibitori
activ
modifi
warhead
structur
seem
favour
bind
addit
interact
oxyanion
hole
pstack
pyrazolon
comparison
compound
dock
enzym
similar
bind
pose
crystal
structur
obtain
supplementari
fig
contribut
method
coval
proteintempl
assembl
irrevers
enzym
inhibitor
describ
implement
approach
combin
revers
dynam
fragment
ligat
reaction
irrevers
coval
modif
inhibit
target
enzym
coxsacki
viru
proteas
start
point
discoveri
proteinbind
fragment
biselectrophil
warhead
epoxyaldehyd
combin
electrophil
motif
irrevers
inhibit
cystein
proteas
epoxid
aldehyd
electrophil
dynam
ligat
nucleophil
fragment
warhead
alon
weak
inhibitor
proteas
enabl
sensit
detect
proteinbind
fragment
pyrazolon
collect
nucleophil
fragment
use
fretbas
assay
proteas
activ
could
demonstr
revers
form
ligat
product
led
enhanc
protein
inactiv
rate
result
strongli
overaddit
inhibit
proteas
inhibit
templat
effect
proteas
confirm
mass
spectrometri
show
inhibit
proteas
activ
correspond
shift
equilibrium
proteinfragmentwarhead
complex
thu
result
coval
modif
enzym
activ
site
develop
potent
irrevers
inhibitor
enterovir
proteas
valid
hit
fragment
obtain
inhibitor
assembl
assay
modifi
vari
electrophil
warhead
attach
fragment
endeavor
start
irrevers
inhibitor
rel
inactiv
rate
warhead
combin
fragment
furnish
potent
irrevers
inhibitor
sever
michael
acceptor
pronounc
e
olefin
like
compound
k
inact
k
z
olefin
like
compound
k
inact
k
respect
vinyl
sulfon
inhibitor
k
inact
k
test
activ
inhibitor
panel
six
enterovir
proteas
indic
potent
inhibitor
broadspectrum
inhibitor
famili
genet
relat
proteas
potent
inhibitor
show
halfmaxim
inhibitori
activ
submicromolar
concentr
broadspectrum
inhibit
enterovir
proteas
highli
desir
develop
drug
applic
case
numer
diseas
caus
alreadi
known
newli
emerg
enterovirus
compound
also
valid
inhibitor
set
four
human
proteas
possess
nucleophil
activesit
residu
found
inact
concentr
mm
result
indic
select
inhibitor
enterovir
proteas
confirm
select
recognit
pyrazolon
fragment
pocket
enterovir
proteas
select
bind
substrat
contain
glutamin
contrari
test
serinecystein
proteas
arginin
trypsin
factor
xa
hydrophob
residu
chymotrypsin
aspart
bind
inhibitor
crystal
structur
complex
proteas
compound
pdb
final
confirm
initi
hypothesi
proteinbind
fragment
detect
sitespecif
manner
via
templat
ligat
reaction
biselectrophil
probe
furnish
irrevers
proteas
inhibitor
beyond
discoveri
class
irrevers
nonpeptid
inhibitor
enterovir
proteas
work
demonstr
potenti
broader
concept
identifi
revers
form
bioactiv
fragment
ligat
product
coupl
dynam
ligat
reaction
irrevers
alkyl
protein
target
concept
protein
templat
bind
initi
fragment
shift
ligat
equilibrium
therebi
induc
protein
modif
reaction
method
princip
applic
protein
surfac
provid
follow
three
condit
met
proteinbind
nucleophil
fragment
biselectrophil
warhead
abl
bind
fragment
nucleophil
nucleophil
protein
site
enabl
irrevers
reaction
biselectrophil
consequ
success
method
altern
protein
target
expect
bound
fragment
biselectrophil
nucleophil
protein
site
fit
spatial
term
chemic
reactiv
also
note
howev
demonstr
present
work
initi
detect
fragmentwarhead
combin
optim
chemic
modif
protocol
reaction
scheme
chemic
synthesi
compound
well
methodolog
inform
report
supplementari
method
character
puriti
compound
articl
see
supplementari
fig
ident
puriti
compound
determin
chromatographi
silica
hplc
fulli
assign
hand
cnmr
spectra
highresolut
mass
spectra
protein
assay
perform
recombinantli
express
viral
proteas
neg
control
set
omiss
proteas
posit
control
set
omiss
inhibitor
control
autofluoresc
substrat
inhibitor
carri
interfer
assay
readout
unless
note
otherwis
k
v
max
valu
determin
doubl
reciproc
plot
measur
activ
concentr
substrat
lineweaverburk
enzym
kinet
determin
fluorimet
safir
ii
tecan
crailsheim
germani
assay
conduct
polystyren
plate
corn
model
mass
spectrometri
proteininhibitor
sampl
highresolut
mass
spectra
record
synapt
hdm
water
co
milford
uk
equip
acquiti
uplc
phenomenex
jupit
column
mm
mm
ioniz
transfer
paramet
ms
system
optim
standard
sampl
insulin
appli
without
modif
deconvolut
measur
result
perform
method
masslynx
softwar
water
co
import
sourc
paramet
capillari
voltag
kv
sampl
cone
v
sourc
offset
v
sourc
temperatur
desolv
temperatur
desolv
ga
flow
l
h
chromatograph
condit
start
solvent
within
min
linear
gradient
solvent
min
solvent
within
min
back
solvent
solvent
composit
awat
formic
acid
bacetonitril
formic
acid
flow
rate
ml
min
mass
spectra
proteaseinhibitor
complex
articl
see
supplementari
fig
recombin
protein
product
purif
enzymat
activ
proteas
coxsacki
viru
consist
aminoacid
residu
carri
addit
ctermin
sixfold
histidin
tag
express
plasmid
novagen
cdna
proteas
correspond
genbank
access
protein
product
purif
follow
standard
condit
briefli
clone
e
coli
cell
transfect
code
plasmid
grown
lb
medium
presenc
ampicillin
mg
ml
od
reach
express
induc
ad
iptg
final
concentr
mm
incub
carri
h
cell
harvest
centrifug
lyse
ultrason
mm
trishcl
ph
mm
vv
triton
vv
mm
dtt
extract
clarifi
centrifug
separ
ninta
agaros
qiagen
mm
trishcl
ph
mm
nacl
appli
step
gradient
mm
imidazol
eluat
highest
volum
activ
pool
separ
prepar
superdex
column
ge
healthcar
equilibr
mm
hepesnaoh
ph
mm
nacl
final
pool
recombin
proteas
adjust
vv
glycerol
frozen
aliquot
use
proteas
express
purif
conduct
previous
describ
proteas
obtain
european
viru
archiv
http
wwweuropeanvirusarchivecom
assay
templateassist
assembl
proteas
inhibitor
activ
proteas
measur
hydrolysi
fretsubstr
ndabcylktlealfqkgppvy
edan
nh
peptid
purchas
biosyntan
berlin
germani
sampl
irradi
light
wavelength
nm
emit
light
nm
measur
rel
fluoresc
unit
rfu
amount
pmol
cleav
substrat
equal
rfu
assay
sampl
contain
ml
mm
hepesnaoh
buffer
solut
ph
mm
edta
ml
enzym
solut
mm
pro
ml
mm
substrat
solut
dissolv
buffer
ml
inhibitor
andor
fragment
dissolv
dmso
assay
result
dilut
seri
mixtur
comparison
reaction
product
depend
assay
solvent
see
supplementari
fig
screen
procedur
consist
follow
step
ml
mm
hepesnaoh
buffer
solut
ph
mm
edta
place
caviti
plate
polystyren
corn
ml
enzym
solut
mm
proteas
mm
hepesnaoh
buffer
solut
ph
mm
edta
ad
plate
shaken
min
rpm
afterward
ml
dmso
solut
electrophil
probe
ml
dmso
solut
nucleophil
ad
follow
ml
substrat
solut
mm
mm
hepesnaoh
buffer
solut
ph
mm
edta
plate
shaken
min
rpm
gener
fluoresc
signal
measur
safir
ii
fluorimet
tecan
electrophil
probe
use
concentr
mm
screen
lower
proteas
activ
eighthundr
fifti
primari
amin
test
concentr
mm
fragment
amplifi
inhibitori
activ
potent
posit
control
sampl
contain
dmso
instead
probe
nucleophil
neg
control
sampl
contain
activ
enzym
interf
fluoresc
effect
observ
determin
inhibitori
paramet
inhibitor
assay
setup
mention
ml
dmso
solut
inhibitor
use
instead
probe
nucleophil
differ
concentr
inhibitor
test
least
duplic
pseudofirstord
associ
kinet
k
ob
determin
use
graphpad
prism
slope
plot
differ
k
ob
valu
inhibitor
concentr
yield
k
inact
k
vitro
proteolyt
activ
assay
volum
ml
reaction
mixtur
contain
mm
proteas
mm
substrat
peptid
dmso
buffer
mm
tri
ph
mm
nacl
mm
hepe
ph
mm
nacl
option
differ
concentr
inhibitor
incub
h
reaction
quench
addit
final
concentr
tfa
sampl
analys
hplc
sourc
st
column
use
linear
gradient
acn
tfa
proteas
activ
absenc
inhibitor
defin
follow
peptid
gl
biochem
shanghai
china
dissolv
dmso
concentr
mm
use
test
proteas
activ
tabl
reaction
proteas
inhibitor
proteas
mix
molar
excess
inhibitor
incub
overnight
complex
purifi
gel
filtrat
superdex
ge
healthcar
mm
tri
ph
mm
nacl
mm
dtt
collect
fraction
concentr
mg
ml
crystal
crystal
structur
determin
crystal
grown
sittingdrop
vapour
diffus
method
mix
equal
volum
protein
solut
reservoir
solut
contain
polyethylen
glycol
ammonium
acet
bistri
ph
crystal
transfer
cryoprotect
solut
compris
mother
liquor
glycerol
second
flashcool
liquid
nitrogen
xray
diffract
data
collect
beamlin
xaloc
alba
synchrotron
cerdanyola
del
barcelona
tabl
diffract
data
index
integr
use
xd
scale
merg
scala
structur
elucid
refin
carri
use
suit
program
initi
phase
obtain
molecular
replac
use
phaser
previous
solv
structur
search
model
pdb
code
refmac
employ
structur
refin
coot
interpret
electron
densiti
model
build
geometri
restraint
inform
gener
sketcher
within
stereo
imag
electron
densiti
map
bind
site
proteaseinhibitor
complex
see
supplementari
fig
crystal
structur
valid
molprob
show
residu
ramachandranfavour
ramachandranallow
region
protein
ligand
dock
analysi
protein
data
bank
entri
use
structur
proteas
detail
bind
confirm
inhibitor
ligand
dock
see
supplementari
fig
dock
perform
use
gold
v
cambridg
crystallograph
data
center
cambridg
uk
europ
protein
prepar
use
moe
version
ref
bind
site
defin
use
radiu
around
sulfur
atom
cystein
dock
carri
use
plp
score
function
ga
run
per
ligand
accur
mode
without
water
molecul
default
paramet
set
coval
dock
perform
constrain
sulfur
atom
ligand
cystein
share
posit
coordin
dock
pose
analys
priorit
pocket
bind
put
coval
bond
format
use
pharmacophor
model
develop
ligandscout
version
ref
base
crystal
structur
proteas
graphic
represent
select
conform
gener
use
pymol
molecular
graphic
system
version
llc
data
avail
data
support
find
studi
avail
within
articl
supplementari
inform
file
correspond
author
upon
reason
request
crystal
structur
present
within
articl
deposit
pdb
code
acakdggifaqksrdrhylvgtvnh
acrhsvgatlealfqkgppvyreikisnh
acrhsvgatlealfqkgppvyreikisnh
acrhsvgatlealfqkgppvyreikisnh
acrhsvgatlealfqkgppvyreikisnh
acrhsvgatlealfqkgppvyreikisnh
